
Number of publications published per year by Yin, Deling. (Source : PubMed)

Distribution of publications types for Yin, Deling. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
CTGF associated with oncogenic activities and drug resistance in glioblastoma multiforme (GBM).
Int. J. Cancer
2010
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study.
Lancet Oncol.
2010;11;2

Critical role of toll-like receptor 9 in morphine and Mycobacterium tuberculosis-Induced apoptosis in mice.
PLoS ONE
2010;5;2

A role for the clock gene per1 in prostate cancer.
Cancer Res.
2009;69;19

The integration of real and virtual magnetic resonance imaging experiments in a single instrument.
Rev Sci Instrum
2009;80;9

Insulin-stimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle.
J. Clin. Endocrinol. Metab.
2009;94;9
Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
Cancer Res.
2009;69;14


Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysis.
Cancer
2009;115;11

Efficient gene therapy-based method for the delivery of therapeutics to primate cortex.
Proc. Natl. Acad. Sci. U.S.A.
2009;106;7

Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
J. Immunol.
2009;182;3
[ See timeline ] [ See all publications ]
means that Yin, Deling has 19 papers cited a least 19 times - methodology
Division of Hematology and Oncology, Cedars-Sinai Medical Center, University of California-Los Angeles School of Medicine, Los Angeles, California 90048, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.